American International Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,095
| Closed | -$808K | – | 1450 |
|
|
2024
Q1 | $808K | Buy |
20,095
+1,209
| +6% | +$48.6K | ﹤0.01% | 1411 |
|
|
2023
Q4 | $481K | Sell |
18,886
-76
| -0.4% | -$1.94K | ﹤0.01% | 1682 |
|
|
2023
Q3 | $264K | Buy |
18,962
+674
| +4% | +$9.37K | ﹤0.01% | 1970 |
|
|
2023
Q2 | $420K | Buy |
18,288
+39
| +0.2% | +$897 | ﹤0.01% | 1759 |
|
|
2023
Q1 | $541K | Buy |
18,249
+363
| +2% | +$10.8K | ﹤0.01% | 1556 |
|
|
2022
Q4 | $446K | Sell |
17,886
-65
| -0.4% | -$1.62K | ﹤0.01% | 1655 |
|
|
2022
Q3 | $391K | Buy |
17,951
+253
| +1% | +$5.51K | ﹤0.01% | 1728 |
|
|
2022
Q2 | $348K | Buy |
17,698
+638
| +4% | +$12.5K | ﹤0.01% | 1828 |
|
|
2022
Q1 | $722K | Sell |
17,060
-1,201
| -7% | -$50.8K | ﹤0.01% | 1516 |
|
|
2021
Q4 | $1.16M | Sell |
18,261
-546
| -3% | -$34.7K | 0.01% | 1334 |
|
|
2021
Q3 | $1.11M | Buy |
18,807
+2,609
| +16% | +$153K | 0.01% | 1389 |
|
|
2021
Q2 | $786 | Buy |
16,198
+10,321
| +176% | +$501 | ﹤0.01% | 1647 |
|
|
2021
Q1 | $228 | Buy |
5,877
+16
| +0.3% | +$1 | ﹤0.01% | 2300 |
|
|
2020
Q4 | $363 | Buy |
+5,861
| New | +$363 | ﹤0.01% | 1931 |
|